The primary end point of the study, major molecular response at 12 months, was achieved by 69% of patients. Approximately a ...

Minimal residual disease is “a credible intermediate endpoint” for some patients with newly diagnosed acute myeloid leukemia, researchers report.

The latest update is out from Enliven Therapeutics ( (ELVN) ).

Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the ...

A new study suggests everyday movements may cause temporary back flares, but not long-term damage — so you can stay active ...

Funeral director George Locke, who’s never watched a boxing match, is stepping into the ring to raise cash for Shipston ...

Most Medicare beneficiaries reported manageable treatment burdens from health care. Among Medicare beneficiaries with heavier chronic condition burdens, 1 in 4 Medicare Advantage enrollees faced high ...

Urbana's Bluestem Hall Nature School sits on 120 acres of prairie and was designed to connect its students to nature. But ...

Understand brain fog in progressive MS, its causes, and treatments. Learn self-help strategies to manage daily life, improve ...

More than 700 Illinois schools are within a quarter-mile of crop fields, yet state law doesn’t require pesticide applicators to notify them before spraying. Advocates say a new notification proposal ...

Is a new obesity drug making people lose too much weight? Plus catch up on #ASH25 and hear how the country's scientific ...